Technical Analysis for NVIV - InVivo Therapeutics Holdings Corp.

Grade Last Price % Change Price Change
D 1.15 -4.17% -0.05
NVIV closed down 4.17 percent on Friday, February 26, 2021, on 35 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical NVIV trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
50 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -4.17%
Stochastic Reached Oversold Weakness -4.17%
Wide Bands Range Expansion -4.17%
Oversold Stochastic Weakness -4.17%
Calm After Storm Range Contraction -10.16%
Older End-of-Day Signals for NVIV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support 3 days ago
60 Minute Opening Range Breakdown 3 days ago
Down 5% 3 days ago
Fell Below 50 DMA 3 days ago
Up 1% 3 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


InVivo Therapeutics Holdings Corp. Description

Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). The company is developing a Neuro-Spinal Scaffold, an investigational bioresorbable polymer scaffold for the implantation at the site of injury within a spinal cord contusion; and biocompatible Neuro-Spinal Scaffold Plus Stem Cells to treat chronic SCI. Its proprietary technologies incorporate intellectual property licensed under exclusive, worldwide license from Boston Children's Hospital and the Massachusetts Institute of Technology, as well as intellectual property that has been developed internally in collaboration with advisors and partners. The company was founded in 2005 and is based in Cambridge, Massachusetts.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Organ Systems Stem Cells Injury Injuries Nervous System Spinal Cord Biomaterials Biomaterial Medical Emergencies Spinal Cord Injury Neurotrauma

Is NVIV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 5.8318
52 Week Low 0.4975
Average Volume 6,224,301
200-Day Moving Average 1.24
50-Day Moving Average 1.13
20-Day Moving Average 1.43
10-Day Moving Average 1.45
Average True Range 0.20
ADX 31.11
+DI 27.47
-DI 28.76
Chandelier Exit (Long, 3 ATRs ) 1.41
Chandelier Exit (Short, 3 ATRs ) 1.66
Upper Bollinger Band 1.83
Lower Bollinger Band 1.03
Percent B (%b) 0.15
BandWidth 56.50
MACD Line 0.03
MACD Signal Line 0.10
MACD Histogram -0.0728
Fundamentals Value
Market Cap 24.35 Million
Num Shares 21.2 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -0.89
Price-to-Sales 0.00
Price-to-Book 1.74
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.33
Resistance 3 (R3) 1.33 1.28 1.30
Resistance 2 (R2) 1.28 1.23 1.27 1.29
Resistance 1 (R1) 1.21 1.20 1.18 1.21 1.28
Pivot Point 1.16 1.16 1.14 1.15 1.16
Support 1 (S1) 1.09 1.11 1.07 1.09 1.02
Support 2 (S2) 1.04 1.08 1.04 1.01
Support 3 (S3) 0.97 1.04 1.00
Support 4 (S4) 0.97